Rapid emergence of arsenic pollution demands the development of novel adjunct with non-invasive painless oral therapeutic agent to combat against arsenic associated health hazards by replacing conventional painful chelating therapy. In the present study, the modulatory effects of vitamin B and folic acid (folate) in the amelioration of arsenic mediated uterine disorders were examined.
Introduction
Drinking arsenic contaminated water creates abrupt threats to the public health and future prospects of agriculture and industries in the affected areas in several countries. The World Health Organization has set a provisional guideline for a tolerable limit of arsenic in drinking water, whereas in Asian countries like Bangladesh and India the level is 40 times higher than the recommended safe limit (Chattopadhyay 2002) . Arsenic imposes its unfavorable effect on fetal growth directly and may also inhibit the transportation of nutrient to the fetus by damaging the placental tissue via oxidative stress (Rahman 2009) . Long term arsenic exposure can cause male and female reproductive hazards with alteration of ovarian and testicular steroidogenesis, disruption of ovarian and testicular tissue, arrestation of spermatogenesis and folliculogenesis etc. Sodium arsenite can suppress the activity of hypothalamico-pituitarygonadal axis and resist the natural folliculogenesis by inhibiting the plasma FSH and LH levels (Chattopadhyay and Ghosh, 2010) . The adverse effect is also noted on hypothalamicopituitary-adrenal axis in arsenic affected rats due to low level of gonadal steroidogenesis. Arsenic increases the ACTH from the pituitary that sustains the hypertrophy of the adrenal gland and elevates the synthesis of ∆ , HSD (hydroxysteroid dehydrogenase), plasma corticosterone (Chattopadhyay , 2003) . Arsenic mediated reproductive hazards may be due to the disturbance in signaling pathway of the steroid hormone (Nakareangrit 2015) by the regulation of gene expression and not by the receptor itself (Davey 2007) . Arsenic induces lesions in the rat uterus and is subsequently primed to reproductive failures by mimicking an estrogenic mechanism (Stoica , 2000) . Arsenic treatment substantially down regulates the expression of vascular endothelial growth factor (VEGF) in the uterus and estrogen receptor alpha. Arsenic may suppress the action of estradiol altering cell cycle regulatory proteins like CDK4 and cyclin D1 (Chatterjee and Chatterji, 2010) . Inside cells, reactive oxygen species (ROS) are formed during metabolic processing of the arsenicals and results in tissue injury. One-carbon (1C) metabolism is important in the methylation of arsenic via S-adenosylmethionine (SAM). Folic acid (FA) and cobalamin (B ) are involved in this process by regulating the status of homocysteinemia internally in response to arsenic exposure (Gamble 2006) . Earlier, B and folic acid has been reported to act as synergistic safeguards in hepatic arsenic detoxification (Chattopadhyay 2012) , but reproductive benefits have yet to be documented. Very often it is seen that detoxification of toxin from the liver is not essentially sufficient to protect other organs. Arsenic exposed female population often suffers from infertility (Chattopadhyay 2003) . The available drug British Anti Lewsite (BAL) against arsenic manifests with moderate to severe side effects. Thus, the aim of this study was to elucidate the role of non-invasive oral application of B and folic acid in the amelioration of arsenic mediated uterine degeneration. , et al., et al. et al., et al., et al. et al., et al., et . The estrous cycle of all rats was synchronized by oral dose of estradiol of 1.0 µg 100 g b. wt. The experiment was started on the same day when all the rats showed synchronization in their estrous cycle. Drinking water contaminated with sodium arsenite (As ) with 0.4-ppm and administered in rat per 100 g b.wt. per day for 28 days. Vitamin B and Folic acid were supplied through gavages. Animals were sacrificed on day twenty nine. Serum was separated and organs were dissected out for biochemical and histological examinations and preserved at -20ºC in several aliquots.
Rats were divided equally as follows: Uterine tissue was homogenized (20% w/v) in ice-cold phosphate buffer (0.1 mol l , pH 7.4). The supernatant was collected by centrifugation at 15,000×g at 4°C for 3 min for the estimation of malondialdehyde (MDA) and conjugated dienes (CD). The MDA was determined from the reaction of thiobarbituric acid with MDA. The amount of MD 105 mol cm ) (Jendryczko and Drózdz, 1988) . The CD was determined by a standard method, where lipids were extracted with chloroform-methanol (2:1) and centrifuged at 1,000×g for 5 min. The lipid residue was dissolved in 1.5 ml of cyclohexane, and finally, the amount of hydroperoxide formed was measured at 233 nm (Okhawa 1989) . with 20 µl serum at 170 V. Agarose gel was developed with slight modification in the presence of H O, 1.0 M Tris, tetrazolium-blue, phenazine-methosulphate, Na-lactate and NAD and then incubated at 37ºC to develop color reaction for 30 min following the insing of the gels with water and observed under light exposure (Brandt 1987) .
Uterine horns were used for DNApreparation and the cell pellet was treated with 500 l lysis buffer (50 mM Tris, pH 8.0, 20 mM EDTA, 10 mM NaCl, 1% SDS, 0.5 mg ml proteinase K) for 15 min at 4°C and centrifuged in chilled conditions at 12,000×rpm for 20 min. The supernatant was collected and treated with 1:1 mixture of phenol: chloroform with gentle agitation for 5 min and precipitated in two parts of cold ethanol and one tenth part of sodium acetate (Garcia-Martinez 1993) . After spinning down an omet assay was performed following the method of . To a 25 ml of cell suspension (105 cells) low melting point agarose (0.6%) was added in PBS at 37ºC and electrophoresed. Following the completion of electrophoresis for 30 min at 25 V and 300 mA, slides were then neutralized with PBS and stained with a solution of 10 mg ml ethidium bromide for 5 min. Washing with water, excess stain was removed. Slides were analyzed using a fluorescence microscope (Nikon, Eclipse LV100 POL), with the VisComet (ImpulsBildanalyse) software.
The uterine horns were embedded in paraffin laterally, a semiautomated microtome (Leica Biosystems). Sections were stained with eosin and hematoxylin (Harris) and observed under a microscope (Nikon, Eclipse LV100, magnification ×400) to evaluate the histological changes. Fractalyse 2.4 software was used to analyze the surface morphology and fractal dimension of uterus from its histological image to assess possible fibrotic status.
UN-SCAN-IT gel 7.1 software was used to measure the band intensity with respect to the control band (100%). Data from the arsenic ingested group or B vitamins co-administered group were compared with control by utilizingANOVA, followed by multiple comparison two tailed t-test.
The current results suggest that trivalent form of arsenic yields reactive oxygen species in association with H O , and thus forms several lipid peroxides and conjugated diene as the end products. A significant elevation was observed in the uterine MDA 
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Paoletti , 1990).
Catalase activity was assayed spectrophotometrically using same homogenate (Sinha, 1972) . The reaction was stopped at different time intervals by the addition of a dichromateacetic acid mixture and H O and was determined as chromic acetate. One unit of catalase activity was expressed as a mole of H O consumed min mg protein.
Uterine horns were homogenized (20% w/v) in ice cold PBS (1M, pH 7.4) centrifuged at 10,000 × for 20 min at 4°C. A 12% SOD activity gel assay system was used for electrozymographic imprint. The SOD active site developed a clear area of achromatic bands competing with nitroblue tetrazolium for O radical (Christine , 2010) . The gel was scanned when maximum contrast between the band and background was achieved.
A electrophoresed on 8% PAGE for catalase activity. Gels were kept at 0.003% H O solution for 10 min and then placed in the staining mixture which contained 2% potassium ferricyanide and 2% ferric chloride. Bluish yellow bands were appearing against a blue green background.
Uterine tissues were homogenized in 0.1 M of phosphate buffer solution (pH 7.0) and centrifuged at 18,000 x g for 15 min at 5ºC (Sadasivan and Manickam, 1966) for enzymatic assay of peroxidase. A cocktail of 20 Mm of guiacol and 0.1 ml of supernatant was read in the presence of 0.3 ml of H O (12.3 mM) as substrate. The time was noted when the absorbance increased (436 nm) by 0.1 unit.
For the electrozymogram study of uterine peroxidase uterine horns were homogenized (20%;w/v) in ice cold PBS (0.1M pH 7.4) and centrifuged at 10,000 × for 20 min at 4°C and extracted protein was loaded at 8% native gel. Peroxidase zymogram was developed by benzidine in 30% H O solution till the appearance of brown colour (Hathama and Nuha, 2014) .
Using Tulip Assay kit from Tulip India Group, total serum LDH activity was assayed from the decrease in absorbance of oxidation of NADH to NAD. This decrease in absorbance was proportional to the LDH activity in the sample.
For an electrozymographic study of the enzyme agarose gel of 1.2% in 50 mM Tris-HCl buffer pH 8.2 was electrophoresed The reaction mixture was prepared by mixing 800 μl of TDB (Merck), 40 μl of 7.5 μl of EDTA-MnCl μl of the tissue supernatant. The activity of SOD in this mixture was monitored at 340 nm from the rate of oxidation of NADPH ( 50 μg protein per sample was (323%) and CD (129%) level in the arsenite-induced group compared to the control group (Fig. 1) . Regarding SOD inhibition, it may be clarified that uterine tissue may face an increased production of superoxide anion (O ) in response to arsenic ingestion as a consequence of diminished conversion of superoxide anion radical to H O in uterine tissue. Henceforth, this enzymatic exhaustion, as shown electrozymographically, indicates a generation of free radicals in uterus during arsenic metabolism. (Fig. 2) .
In the present study, a significant diminution in uterine SOD (200%), catalase (180%) and peroxidase (316%) activities were observed ( Fig.2A, Fig. 3A ) in arsenic-exposed versus control group when spectrophotometric determination w a s p e r f o r m e d f o r t h e s e e n z y m e s . M o r e o v e r, electrozymogram shown in Fig.2B , 2C and 3C revealed that the electrophoretic intensity of these three enzymatic bands was reduced in arsenic ingested group significantly in comparison to vehicle treated control. Reduced antioxidative enzymatic activities were addressed for cell cycle arrest (2/M phase), 2 2 2 -necrosis and apoptosis in the male reproductive organ (Fang , 2013) .
In the present study, arsenic ingestion induced uterine DNA laddering and smearing (Fig. 5A) ; and single cell DNA damage due to excess free radicals (Fig. 5B) . This incidence may promote the induction of necrotic and apoptotic changes in uterine tissue (Ciaccio , 1998) . The formation of ROS may finally lead to DNA damage by trivalent arsenicals and also initiating a suppression of DNA repair systems as well as repair of oxidative DNA damage. Arsenic (III) may influence hypomethylation of uterine DNA in expense of a well-known methyl donor of arsenic metabolism S-adenosyl methionine (SAM). Necrotic and apoptotic tissue death along with extreme DNA damage were validated by the arsenicals and its methylated derivative and this might be further influenced by the alteration in SOD activity (Kligerman , 2003; Salnikow and Zhitkovich, 2008) .
LDH is also designated to be a cancer-specific biomarker and is not generally increased in patients without (Fig. 7) , may be validated by the elevated serum LDH level (Gimeno , 1979) following arsenic ingestion (Fig. 4) . Fractal dimension assessment of histological section was recently used to reveal
.
the fibrotic status of the tissue and in the present study found an increase in fractal dimension in the stained tissue of arsenic treated group (Fig. 6 ). This may indicate that there may be the increased fibrosis of the uterus in arsenic treated group as a probable consequence of increased collagen deposition in the uterus (Zouein , 2014) . Significantly increased LDH level (58%) in arsenic exposed rats in the present investigation (Fig.  4) may play a decisive role in the fibrotic changes of the organ by stimulating collagen deposition (Judge 2015) . Deficiency of these two B vitamins may be accounted for the elevation of serum LDH level (McCarthy , 1966) .Hence, maintenance of adequate levels of these B vitamins may play an imperative role to prevent uterine necrosis.
Since estrogen induces peroxidase activity in uterine cells; hence, estrogen plays a decisive role in the restoration uterine peroxidase activity as well as uterine development and proliferation (DeSombre and Lyttle, 1979) . Another possibility for such uterine cellular malformation (Fig. 6) organ weight (Table1) in arsenic treated group may be the consequence of downregulation of plasma estradiol signaling (data not shown) due to the generation of free radicals as indicated by the existence of asynchronized estrous cycles (4.1 ± 0.2 cycles per animal); dominated by consistent diestrus, following arsenic exposure when compared with control (7.2 ± 0.2 cycles per animal) in the present study. Data from the previous studies implied that the inhibitory role of sodium arsenite on key ovarian steroidogenic enzyme ( , 3 -HSD and 17 -HSD) activities may interrupt ovarian estradiol synthesis (Chattopadhyay and Ghosh, 2010; Chattopadhyay , 2003) . Additionally, low plasma levels of FSH and LH downregulate the activities of these steroidogenic enzymes (Chattopadhyay and Ghosh, 2010; Chattopadhyay , 2003) . Uterine injury was primarily due to the remarkable loss of secretory cells of uterine tissue along with the distortion of endometrial layer. B and folic acid co-treatment significantly secured such As induced uterine-disorders (Fig.6) . These defensive mechanisms of B and folate might have ended arsenic induced apoptotic stimuli and sheltered uterine tissues from the necrotic damages since there was an improvement in the uterine histopathological status (Fig.6 ) and DNA smears ( response to these vitamins' co-administration in As ingested rats. Further studies are necessary to make a more conclusive report. Significant drop in the fractal dimension of uterine tissue in a dose dependent manner, following the treatment with vitamin B and folate alone or in combination with arsenic exposed rats (Fig. 5-6 ) was also observed. It may be postulated that possible fibrous change due to probable excess collagen deposition in the uterine tissue may be reversed by the co-administration of vitamin B and folate by reducing the level of circulating homocysteine (Jayarajah, 2005) .
However, animals in the vitamin-supplemented group showed a re-established morphology as compared to those in arsenic-exposed group. In our previous investigation, we confirmed 7 estrous cycles with low dose (0.4 ppm) of arsenic treatment significantly increased arsenic concentration in uterine tissues (Chattopadhyay and Ghosh, 2010) . A high tissue arsenic concentration is obviously allied with the impaired antioxidant status and tissue damages. This most likely reflects the perception that inorganic arsenic may be associated with reduced plasma level of vitamin B and folate, thereby reducing the arsenic detoxification by a delay in the biliary excretion of arsenic (Kile and Ronnenberg, 2008) . Hence, exogenous vitamin B and folate may promote biliary excretion of arsenic in the methylated form (As III).
Methylation of arsenic has been implicated in the excretion, removal and detoxification of arsenic from the system. Methyl cobalamin (CH B ), a derivative of vitamin B , and reduced glutathione (GSH) are projected as the coenzymes and are required in the methylation of inorganic arsenic in association with SAM (Nakamura, 2011). It has already been explored that arsenic is detoxified through methylation reaction involving Sadenosylmethionine and the enzyme methyl transferase. In addition, SAM contributes methylation of As (III) via one-carbon metabolism to yield methylarsonic acid (MMAs) and Sadenosylhomocysteine followed by the generation of homocysteine and adenosine by the hydrolysis of Sadenosylhomocysteine (Hall and Gamble, 2012) . This is managed largely by downstream remethylation of homocysteine by methionine synthase using N -methyltetrahydrofolate as a cosubstrate which is crucial for the regeneration of SAM and removal of arsenic. Hence, folate metabolism extremely requires the involvement of methionine synthase for the maintenance of folic acid pool in the body. Folic acid also supports the maintenance of endogenous methionine level by the conversion of homocysteine to methionine. Arsenic is necessarily oxidized from its (III) to (V) state during the process of its methylationdriven detoxification. Their intracellular levels are regulated by folate and B (Kligerman , 2003) . This study advocates a possible effective drainage of free radicals, which might be helpful in tissue/ DNAprotection.
Removal of arsenic from the organs is important for reducing uterine stress and normalization of its morphology. However, the synthesis of endogenous methionine from Sadenosylhomocysteine is ultimately catalyzed by the expansion of endogenous methionine due to the involvement of B as a cofactor for methionine synthase. Hence, the therapeutic measures retrieved by vitamin supplementation at physiological concentration in this study may promote the methylation process and make it possible to eliminate arsenic through urine. As a consequence of low circulating level of folate increased tissue retention and toxicity of inorganic arsenic is possible due to the restricted biotransformation and excretion of inorganic arsenic. Therefore, arsenic methylation, as well as removal demands the participation of folate and homocysteine in this detoxification process (Spiegelstein  2003) .
Nonetheless, the restricted generation of free radicals in arsenic treated group is validated in the present investigation following the co-treatment of these exogenous vitamin B and folate. These vitamins are also allied to the defense of the uterine tissues and genetic materials ensuing in the hindrance of necrosis and probable carcinogenesis (Mukherjee , 2006) .
Furthermore, rebuilding of uterine weight in arsenic affected rats following vitamin B and folate co-treatment (Table- 1) may be due to the safeguarding of ovarian steroidogenesis and plasma gonadotrophin levels. Previous studies have reported that vitamin B and folate may play a crucial role in restoring peroxidase activities in arsenic treated rats (Stokstad , 1980) , and the results in this regard also strengthen this interaction between these two vitamins and peroxidase. In vitamin B and folate co-administered group alone (Vit B -6.0 ± 0.4 cycles/animal; folate-6.3 ± 0.2 cycles / animal) or in combination, the number of estrous cycles was not disparate (7.0 ± 0.2 cycles / animal) from the control level in response to the probable consequence of the preservation of estradiol signaling (Bennett, 2001; Chattopadhyay and Ghosh, 2010) . Cervical dysplasia characterized with the abnormalities of the cell lining of the cervix and uterus is the probable consequence of B deficiency. Folate deficiency reduced circulating testosterone, estradiol and LH levels (Lepkovsky 1951; Wallock Montelius 2007) .
We conclude that, folate and B co-treatment support cellular synthetic mechanism, as well as protect genetic constituent. These two B vitamins execute a role of strong prevention of necrotic tissue degeneration, perhaps by removing arsenic from the uterine tissues. This defense was accommodating the regeneration of tissue structural materials and the amino acid pool. The clinical implications of this study focus on the enormous possibility of combination therapy with important vitamins or other micronutrients or active exogenous ingredients as a nutritional supplement against arsenic-induced organ toxicity and carcinogenesis. However, arsenic is detoxified in the human body during the course of methylation process and methionine plays an imperative role in this. It is suggested that itamin B and folic acid facilitates detoxification of arsenic, and hence, reduces the arsenic induced oxidative stress in uterine tissue although more extensive study is required in this field. Finally, the outcome of the study will be helpful in developing a non-invasive treatment strategy among arsenic affected population from the angle of curing arsenic mediated reproductive disorders. et al., et al. et al. et al., et al., 
